The Antipsychotic Shuffle: Where Do Prescriptions Go When Facilities Cut Back?
When antipsychotics are reduced, it's not always about better mental health outcomes. Families should know what comes next.
Get Palmelle in your Google results.
One tap. Google shows our reporting higher when you search.
I was scrolling through a trade publication on my phone, waiting for a client to call back about a storyboard revision, when I saw a headline that made me stop. It was about how some nursing homes are cutting back on antipsychotics, and the numbers were pretty stark: a 20.8 million prescription dispense increase for these drugs in long-term care facilities and assisted living during the pandemic, according to HHS ASPE [c3]. The article mentioned that when they reduce these drugs, the replacements aren't always benign. It's often a mix of benzodiazepines, antidepressants, and anti-epileptic drugs, as investigators found in VA nursing homes [c1][c2]. I immediately thought about my mom, who's had her share of medication adjustments. I put my phone down and stared out the window for a minute, picturing the sheer volume of pills involved. It’s one thing to read about it; it's another to imagine it happening to someone you care for, especially when the alternatives might have their own set of problems. My complaint with how this is usually framed is that it sounds like a win: 'They're reducing the drugs that have side effects!' And sure, sometimes that's true. But the reality is, a facility might be under pressure to cut costs or meet certain benchmarks, and the easiest way to show progress is to decrease the most scrutinized medications. What gets lost is the actual well-being of the person receiving the care. The standard defense you hear is that these shifts are driven by a desire for better outcomes. A spokesperson for a large facility group might say something like, 'Our goal is always to minimize unnecessary medication and promote independence.' That’s the line, anyway. But here’s the hard truth: reducing antipsychotics can sometimes lead to increased hospitalizations. One study in HCPLive noted that for patients with schizophrenia, dose reduction actually increased both mental health-related and all-cause hospitalizations [c4]. So, the 'improvement' might just be shifting the problem, not solving it. It’s like swapping one leaky faucet for three others that drip at different rates. Here’s the concrete action: before any significant medication changes are made for your parent or the person in their care, ask for a written plan. This plan should detail not just what’s being reduced, but what’s being increased or added, and crucially, what the facility’s protocol is for monitoring for adverse effects from the *new* medications. Don't leave the doctor's office or the facility meeting without it.
The direct answer
When antipsychotic medications are reduced in care facilities, they are often replaced with other classes of drugs like benzodiazepines, antidepressants, or anti-epileptic medications. This shift can be driven by various factors, including facility-level initiatives or regulatory pressures, but it doesn't always lead to improved outcomes and can sometimes increase hospitalizations.
The Usual Suspects: What Replaces Antipsychotics?
When a facility decides to decrease or discontinue an antipsychotic medication, the void is often filled by other psychoactive drugs. One common category is benzodiazepines, such as lorazepam or alprazolam, often prescribed for anxiety or agitation. Another frequent substitute is antidepressants, like SSRIs, which can be used off-label to manage mood swings or behavioral disturbances associated with cognitive decline.
Anti-epileptic drugs, originally designed for seizure disorders, are also frequently employed. Medications like valproic acid or gabapentin can sometimes be used to manage behavioral symptoms, though their primary purpose is different. The specific choices depend on the individual's presentation, the prescribing practitioner's preference, and the facility's established protocols for managing behavioral challenges.
This substitution strategy isn't always a direct, one-to-one replacement aimed at addressing the root cause. It's often a way to manage observable symptoms that might arise when a primary medication is withdrawn. The goal, ostensibly, is to maintain a level of calm and reduce behaviors that staff find disruptive or that might be perceived as indicative of distress, regardless of the underlying mechanism.
Why the Shift Happens: Beyond Just 'Better Outcomes'
While the stated intention behind reducing antipsychotics is often to minimize side effects and promote a more natural state, the decision-making process within facilities can be complex. Regulatory bodies and quality improvement initiatives have pushed for a decrease in the routine prescribing of these medications, particularly for conditions where they may not be the most appropriate long-term treatment.
However, there's also a practical element for care providers. Facilities are often evaluated on various metrics, and a high rate of antipsychotic prescribing can be a red flag. Reducing these prescriptions can improve a facility's standing on certain quality reports. This creates an incentive to decrease their use, sometimes leading to rapid adjustments rather than carefully managed tapers.
Furthermore, the availability of alternative medications that are perceived as less risky or are more familiar to prescribers can influence these decisions. The focus can inadvertently shift from finding the most effective treatment for the individual's specific condition to implementing a strategy that appears favorable on paper and is easier to manage operationally.
Want more of this?
Mark Palmelle a preferred source and it shows up when you search Google.
The Unintended Consequences: When Less Isn't More
The transition away from antipsychotics isn't always smooth. For individuals with schizophrenia or severe agitation, a reduction in their medication can lead to a resurgence of symptoms. This can manifest as increased paranoia, hallucinations, or severe behavioral disturbances that require immediate attention.
One significant concern is the potential for increased hospitalizations. Studies have indicated that reducing antipsychotic doses can, in some cases, lead to a rise in both all-cause and mental health-related hospital admissions [c4]. This suggests that the underlying condition may not be adequately managed by the substitute medications, or that the withdrawal process itself can destabilize an individual.
Beyond hospitalizations, the substitute medications themselves carry their own risks. Benzodiazepines can lead to sedation, confusion, and an increased risk of falls, particularly in older adults. Antidepressants can have a range of side effects, including changes in mood, sleep disturbances, and gastrointestinal issues. Anti-epileptic drugs can cause drowsiness, dizziness, and cognitive impairment. The cumulative effect of these medications, especially when combined, can be significant and may not always be well-monitored.
Common mistakes
- Assuming a reduction in antipsychotics automatically means better care.
While reducing potentially harmful drugs is a laudable goal, it's crucial to understand what replaces them and if those alternatives are truly beneficial or merely a different set of risks. The focus should be on the overall well-being and stability of the individual. - Not actively questioning the medication plan.
Families have a right to understand the rationale behind any medication changes, including the specific drugs being introduced and the monitoring plan. A lack of transparency from the facility should be a red flag.
Frequently asked
What are the common side effects of antipsychotics in older adults?
Common side effects can include drowsiness, dizziness, weight gain, tremors, and a movement disorder called tardive dyskinesia. They can also increase the risk of falls and confusion. Some antipsychotics may also impact heart rhythm.
Are there non-medication approaches to manage behavioral symptoms in care facilities?
Yes, many facilities employ non-pharmacological interventions. These can include environmental modifications, structured activities, music therapy, redirection techniques, and staff training in de-escalation. A comprehensive care plan often integrates these approaches alongside medication.
How can I advocate for my parent if I disagree with medication changes?
Request a meeting with the prescribing physician and the facility's care team. Bring documentation of your parent's history and any concerns you have. Ask specific questions about the new medications, their intended benefits, potential side effects, and the monitoring plan. If you remain unsatisfied, consider seeking a second opinion or consulting with a geriatric pharmacist.
Sources
- PMC — Study on common antipsychotic medication substitutes
- McKnight's Long-Term Care News — Findings on antipsychotic prescribing decreases and alternative medication increases
- HHS ASPE — Report on antipsychotic medication prescribing trends in long-term care facilities
- HCPLive — Study on antipsychotic dose reduction and hospitalization rates
More from Inside the Industry → · Back to Perch · Browse all stories
More of this, in your Google results.
Takes one tap, and it applies everywhere you search — not just this page.